2 completed. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 2 |
Follow Aronora, Inc.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety and Efficacy Study of AB002 (E-WE Thrombin) in End Stage Renal Disease Patients on Chronic Hemodialysis AB002 Dose 1, AB002 Dose 2, placebo - End Stage Renal Disease, Thrombosis | Phase 2 | Completed | Aronora, Inc. | 40 | 2019-07-03 | 2024-03-07 |
| Safety and Efficacy Study of AB023 (Xisomab 3G3) in End Stage Renal Disease Patients on Chronic Hemodialysis AB023- Dose 1, AB023-Dose 2, placebo - End Stage Renal Disease, Thrombosis | Phase 2 | Completed | Aronora, Inc. | 27 | 2018-10-29 | 2024-03-07 |
Kidney Failure, Chronic (2) · Thrombosis (2)
United States (2)